Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolis… Read more
Krka d. d (KRK) - Total Liabilities
Latest total liabilities as of September 2025: zł662.58 Million PLN
Based on the latest financial reports, Krka d. d (KRK) has total liabilities worth zł662.58 Million PLN as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Krka d. d - Total Liabilities Trend (2010–2024)
This chart illustrates how Krka d. d's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Krka d. d Competitors by Total Liabilities
The table below lists competitors of Krka d. d ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mercury Systems Inc
NASDAQ:MRCY
|
USA | $1.04 Billion |
|
Financiere de Tubize SA
LSE:0D53
|
UK | €87.24 Million |
|
Kodiak Gas Services, Inc.
NYSE:KGS
|
USA | $3.12 Billion |
|
Worley Limited
PINK:WYGPF
|
USA | $5.34 Billion |
|
Rush Enterprises A Inc
NASDAQ:RUSHA
|
USA | $2.32 Billion |
|
Science Applications International Corporation Common Stock
NASDAQ:SAIC
|
USA | $3.91 Billion |
Liability Composition Analysis (2010–2024)
This chart breaks down Krka d. d's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Krka d. d's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Krka d. d (2010–2024)
The table below shows the annual total liabilities of Krka d. d from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | zł611.24 Million | +4.93% |
| 2023-12-31 | zł582.52 Million | +6.11% |
| 2022-12-31 | zł548.99 Million | -11.25% |
| 2021-12-31 | zł618.60 Million | +27.88% |
| 2020-12-31 | zł483.73 Million | -6.45% |
| 2019-12-31 | zł517.10 Million | +16.26% |
| 2018-12-31 | zł444.80 Million | +3.10% |
| 2017-12-31 | zł431.43 Million | -7.63% |
| 2016-12-31 | zł467.07 Million | +15.84% |
| 2015-12-31 | zł403.22 Million | -9.15% |
| 2014-12-31 | zł443.85 Million | +3.88% |
| 2013-12-31 | zł427.27 Million | +10.63% |
| 2012-12-31 | zł386.23 Million | -2.04% |
| 2011-12-31 | zł394.27 Million | -9.34% |
| 2010-12-31 | zł434.88 Million | -- |